158 related articles for article (PubMed ID: 38125697)
1.
Xie Y; Li Y; Yang M
J Immunol Res; 2023; 2023():5041223. PubMed ID: 38125697
[No Abstract] [Full Text] [Related]
2. DJ-1 protein expression as a predictor of pathological complete remission after neoadjuvant chemotherapy in breast cancer patients.
Kawate T; Iwaya K; Kikuchi R; Kaise H; Oda M; Sato E; Hiroi S; Matsubara O; Kohno N
Breast Cancer Res Treat; 2013 May; 139(1):51-9. PubMed ID: 23592371
[TBL] [Abstract][Full Text] [Related]
3. DJ-1, a novel biomarker and a selected target gene for overcoming chemoresistance in pancreatic cancer.
Chen Y; Kang M; Lu W; Guo Q; Zhang B; Xie Q; Wu Y
J Cancer Res Clin Oncol; 2012 Sep; 138(9):1463-74. PubMed ID: 22526154
[TBL] [Abstract][Full Text] [Related]
4. Network-based approach to identify prognosis-related genes in tamoxifen-treated patients with estrogen receptor-positive breast cancer.
Wang Y; Gong X; Zhang Y
Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34406386
[TBL] [Abstract][Full Text] [Related]
5. Role of DJ-1 siRNA in reverse sensitivity of breast cancer cells to chemotherapy and its possible mechanism.
Zhang GQ; He C; Tao L; Liu F
Int J Clin Exp Pathol; 2015; 8(6):6944-51. PubMed ID: 26261582
[TBL] [Abstract][Full Text] [Related]
6. Phosphoglycerate kinase-1 is a predictor of poor survival and a novel prognostic biomarker of chemoresistance to paclitaxel treatment in breast cancer.
Sun S; Liang X; Zhang X; Liu T; Shi Q; Song Y; Jiang Y; Wu H; Jiang Y; Lu X; Pang D
Br J Cancer; 2015 Apr; 112(8):1332-9. PubMed ID: 25867275
[TBL] [Abstract][Full Text] [Related]
7. Resistance to cyclin-dependent kinase (CDK) 4/6 inhibitors confers cross-resistance to other CDK inhibitors but not to chemotherapeutic agents in breast cancer cells.
Ogata R; Kishino E; Saitoh W; Koike Y; Kurebayashi J
Breast Cancer; 2021 Jan; 28(1):206-215. PubMed ID: 32860163
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Exosome-Related Gene Risk Model to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Triple-Negative Breast Cancer.
Qiu P; Guo Q; Yao Q; Chen J; Lin J
Front Immunol; 2021; 12():736030. PubMed ID: 34659224
[TBL] [Abstract][Full Text] [Related]
9. FKBP12 is a predictive biomarker for efficacy of anthracycline-based chemotherapy in breast cancer.
Xing M; Wang J; Yang Q; Wang Y; Li J; Xiong J; Zhou S
Cancer Chemother Pharmacol; 2019 Oct; 84(4):861-872. PubMed ID: 31428819
[TBL] [Abstract][Full Text] [Related]
10. Network-based approach to identify prognostic biomarkers for estrogen receptor-positive breast cancer treatment with tamoxifen.
Liu R; Guo CX; Zhou HH
Cancer Biol Ther; 2015; 16(2):317-24. PubMed ID: 25756514
[TBL] [Abstract][Full Text] [Related]
11. Novel association of DJ-1 with HER3 potentiates HER3 activation and signaling in cancer.
Zhang S; Mukherjee S; Fan X; Salameh A; Mujoo K; Huang Z; Li L; To'a Salazar G; Zhang N; An Z
Oncotarget; 2016 Oct; 7(40):65758-65769. PubMed ID: 27582551
[TBL] [Abstract][Full Text] [Related]
12. Clinical significance of DJ-1 as a secretory molecule: retrospective study of DJ-1 expression at mRNA and protein levels in ductal carcinoma of the breast.
Tsuchiya B; Iwaya K; Kohno N; Kawate T; Akahoshi T; Matsubara O; Mukai K
Histopathology; 2012 Jul; 61(1):69-77. PubMed ID: 22385318
[TBL] [Abstract][Full Text] [Related]
13. Expression of DJ-1 in Cancer Cells: Its Correlation with Clinical Significance.
Kawate T; Tsuchiya B; Iwaya K
Adv Exp Med Biol; 2017; 1037():45-59. PubMed ID: 29147902
[TBL] [Abstract][Full Text] [Related]
14. Chemoresistance was correlated with elevated expression and activity of indoleamine 2,3-dioxygenase in breast cancer.
Zhao Y; Wei L; Liu J; Li F
Cancer Chemother Pharmacol; 2020 Jan; 85(1):77-93. PubMed ID: 31844921
[TBL] [Abstract][Full Text] [Related]
15. The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.
Liu SS; Li Y; Zhang H; Zhang D; Zhang XB; Wang X; Yu Y
Theranostics; 2020; 10(23):10729-10742. PubMed ID: 32929377
[No Abstract] [Full Text] [Related]
16. NRG-1 Stimulates Serum DJ-1 Increase in Breast Cancers.
Wang Y; Zhang Y; Lu Q; Wang Y; Sun X; Zhang S
Pathol Oncol Res; 2019 Jan; 25(1):71-79. PubMed ID: 28963699
[TBL] [Abstract][Full Text] [Related]
17. DJ-927, a novel oral taxane, overcomes P-glycoprotein-mediated multidrug resistance in vitro and in vivo.
Shionoya M; Jimbo T; Kitagawa M; Soga T; Tohgo A
Cancer Sci; 2003 May; 94(5):459-66. PubMed ID: 12824894
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy-induced tumor gene expression changes in human breast cancers.
Lee SC; Xu X; Lim YW; Iau P; Sukri N; Lim SE; Yap HL; Yeo WL; Tan P; Tan SH; McLeod H; Goh BC
Pharmacogenet Genomics; 2009 Mar; 19(3):181-92. PubMed ID: 19352302
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological values of PD-L1 expression in HER2-positive breast cancer.
Kurozumi S; Inoue K; Matsumoto H; Fujii T; Horiguchi J; Oyama T; Kurosumi M; Shirabe K
Sci Rep; 2019 Nov; 9(1):16662. PubMed ID: 31723167
[TBL] [Abstract][Full Text] [Related]
20. Diagnostic and prognostic value of serum thioredoxin and DJ-1 in non-small cell lung carcinoma patients.
Fan J; Yu H; Lv Y; Yin L
Tumour Biol; 2016 Feb; 37(2):1949-58. PubMed ID: 26334622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]